Proarrhythmia risk prediction using human induced pluripotent stem cell-derived cardiomyocytes.
Yamazaki D, Kitaguchi T, Ishimura M, Taniguchi T, Yamanishi A, Saji D, Takahashi E, Oguchi M, Moriyama Y, Maeda S, Miyamoto K, Morimura K, Ohnaka H, Tashibu H, Sekino Y, Miyamoto N, Kanda Y.
Yamazaki D, et al. Among authors: sekino y.
J Pharmacol Sci. 2018 Apr;136(4):249-256. doi: 10.1016/j.jphs.2018.02.005. Epub 2018 Mar 3.
J Pharmacol Sci. 2018.
PMID: 29555184
Free article.